Navigation Links
Kuros Announces Allowance of European Patent for Synthetic Biomaterials
Date:6/19/2011

es into the injectable matrices aims to maximize their activity by retention at the site of action. Kuros products are designed to combine ease of application with localized delivery. Kuros has a number of methodologies to achieve the desired retention and release profiles of the biologically active molecules.

Kuros’ has a diverse pipeline of product candidates with its most advanced product candidates being in trauma and wound care.

Since its creation, Kuros has raised over $100 million. The company is located in Zurich, Switzerland.

Press Enquiries

Kuros
Didier Cowling, CEO                        +41(0)44-200-56-62
Alistair Irvine, Director of
Business Development                       +41(0)44-200-56-62

For Swiss Media Enquires:
IRF Communications
Martin Meier-Pfister                        +41(0)43-244-81-40
Jan Gregor                                  +41(0)43-244-81-54

For International Media Enquires:
Citigate Dewe Rogerson
David Dible, Nina Enegren                    +44(0)207-638-9571



'/>"/>
SOURCE Kuros Biosurgery AG
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Pharmacyclics Announces Results of Registered Direct Offering
2. K-V Pharmaceutical Announces Divestiture of Generics Business to Zydus
3. SCOLR Pharma, Inc. Announces Initial Closing of Private Placement
4. Chiltern Announces Additional Investment in Endpoint
5. ACT Announces First Patients Enrolled in Two Clinical Trials Using Embryonic Stem Cells to Treat Stargardts Disease and Dry Age-Related Macular Degeneration
6. Dendreon Announces Webcast Presentation at NASDAQ OMX 26th Investor Program
7. Access Legal Announces Appointment of Nicholas Tubb to Medical Negligence Team
8. Vermillion Announces Joining Russell Microcap® Index
9. Palatin Technologies, Inc. Announces Presentation and Publication on Validation of Scale for Subjective Male Sexual Arousal
10. Merriman Capital Announces Sponsorship of Circadian Technologies on OTCQX
11. INVO Bioscience Announces Planned Submission To ANVISA For Brazilian Approval Following Completion of Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... July 22, 2014 Hussey Copper , ... 29 antimicrobial copper announces Pullman Regional Hospital,s conversion ... EPA-registered antimicrobial solid touch surface, at a nominal cost.  ... MRSA, E-coli and other bacteria within 2 hours of exposure ... against bacteria and infectious diseases in its facilities. ...
(Date:7/22/2014)... Mass. , July 22, 2014  The ... $650 million from philanthropist Ted Stanley ... and bringing new treatments based on molecular understanding ... world. The Stanley commitment – ... the largest for scientific research in general – ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Holomic ... with the debut of its fluorescent immunoassay reader, ... Chemistry (AACC) meeting in Chicago, July 28-31, 2014. ... top versions, the HRDR-300 is a highly sensitive, ... to analyze fluorescent lateral flow immunoassays with high ...
(Date:7/22/2014)... The next session of Clinovo’s ... will comprise of the increasingly popular ‘Base SAS’ and ... a series of technical hands-on classes for entry-level to ... the next step in their professional careers. , The ... Jennifer Kang, Senior Statistician at Genentech and former Senior ...
Breaking Biology Technology:Pullman Regional Hospital changes more than 1,100 touch points to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 2Pullman Regional Hospital changes more than 1,100 touch points to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 3$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 2$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 3$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 4$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 5$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 6$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 7$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 8$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 9$650 million commitment to Stanley Center at Broad Institute aims to galvanize mental illness research 10Holomic to Debut HRDR-300 Fluorescent Immunoassay Reader at the AACC 2014 2Clinovo TechTrainings: Next Session of SAS and CDISC Classes Start 9th September, 2014 2Clinovo TechTrainings: Next Session of SAS and CDISC Classes Start 9th September, 2014 3
... of electrospinning for applications primarily within the medical device ... announces a new technology platform in the field of ... ranging from the nano to microscale. Zeus is able ... and bioabsorbables. The result is a broad range of ...
... Zeus is slated to manufacture parts and assemble MOD® units, an ... ... Orangeburg, SC (PRWEB) February 15, 2009 -- Zeus, Inc., a ... pleased to announce a new partnership with Avancen MOD Corporation. ...
... free webinars providing continuing education for Chemists and Chemical Engineers. Visit ... as a listing of over sixty On-Demand Webinars. For your convenience, the ... , ... Columbia, MD (PRWEB) February 14, 2009 -- Each free ...
Cached Biology Technology:Electrospinning: Emerging New Technology at Zeus 2Zeus Partners with Avancen MOD Corp. 2Free Webinars in Chemistry and Chemical Engineering 2
(Date:7/22/2014)... will hear that drinking milk helps make their bones strong or ... foster the idea that if something is good for us, it ... Journal of Consumer Research , when children hear about the ... "We predicted that when food is presented to children as making ... as learning how to read or count, they would conclude the ...
(Date:7/22/2014)... and Shenzhen, China July 22, 2014 ... subsidiary of BGI, the world,s largest genomics organization, ... human whole exome sequencing service based on Complete ... in-depth bioinformatics analysis and SNP validation, and is ... , Complete Genomics, highly regarded in the ...
(Date:7/22/2014)... -- Nancy Buccola, MSN, APRN, PMHCNS-BC, CNE, Assistant ... Center New Orleans School of Nursing, contributed samples ... genetic material associated with schizophrenia and also suggesting ... schizophrenia. The study, Biological insights from 108 schizophrenia-associated ... in Nature , available at http://www.nature.com/nature/journal/vaop/ncurrent/full/nature13595.html., ...
Breaking Biology News(10 mins):BGI Tech launches human whole exome sequencing service on complete genomics' advanced platform 2LSUHSC contributes to work identifying new DNA regions associated with schizophrenia 2
... a growing body of evidence that continued smoking after a ... survival, risk of other cancers, and quality of life, up ... so or relapse after trying to quit. , The ... a peer-reviewed journal of the American Cancer Society, says smoking ...
... GI infections in families with children in day careUsing an ... infections in the home, according to a study in the ... Greater Boston families -- half of which were given hand ... percent reduction in the spread of GI illnesses. , ...
... how the inhaled form of anthrax disarms bacteria-fighting white blood ... most victims within days. , The lethal toxin in anthrax ... body's first defense against infection, by impairing how they build ... body and eat invading bacteria. , Just two hours of ...
Cached Biology News:Many smokers fail to quit after cancer diagnosis 2Hand sanitizer gel works 2Anthrax stops body from fighting back, study shows 2Anthrax stops body from fighting back, study shows 3
... is a new product number, ... product number. If showing no ... the old Sigma-Aldrich number (Z71,669-3) ... assistance. ID clarifier: barcoded Mfr ...
Rabbit polyclonal to YANK2 ( Abpromise for all tested applications). Antigen: A KLH conjugated synthetic peptide selected within aa 300~400 (C terminal region) of human YANK2. Entrez Gene ID:...
... Freedom EVO96R and Freedom EVO384R are fast ... available in three different sizes, with a ... They deliver significant time saving, with true ... easy setup of your assays with the ...
Request Info...
Biology Products: